fruquintinib,
HMPL-013,
Fruquintinib,
1194506-26-7,
HMPL-013,
Fruquintinib(HMPL-013),
UNII-49DXG3M5ZW,
49DXG3M5ZW,
Fruquintinib (HMPL-013),
HMPL013,
6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide,
6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide,
Fruquintinib [WHO-DD],
Fruquintinib; HMPL-013,
SCHEMBL947183,
GTPL9428,
HMPL 013,
BALLNEJQLSTPIO-UHFFFAOYSA-N,
BCP15692,
EX-A2262,
3-Benzofurancarboxamide, 6-((6,7-dimethoxy-4-quinazolinyl)oxy)-N,2-dimethyl-,
AKOS026750586,
ZINC114898570,
CS-5558,
DB11679,
SB17123,
AK547072,
HY-19912,
B5864,
A14393,
6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide,
6-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-N,2-dimethyl-3-benzofurancarboxamide,
6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide,